IRVING, Texas, Oct. 31, 2011 (GLOBE NEWSWIRE) -- Caris Diagnostics, a leading provider of expert anatomic pathology services, announced today upcoming highlights from the Company's presentations at the American College of Gastroenterology (ACG) 2011 Annual Scientific Meeting being held in Washington, DC from October 29, 2011 to November 2, 2011. In total, Caris is presenting 15 abstracts. Specific highlights consist of new findings that build upon Caris' strong emphasis in gastrointestinal disease research. Two examples are "High Prevalence of Celiac Disease in Women With Young Onset Collagenous Colitis" authored by Ahmed Bedeir, MD, Bhaskar Ganguly, and Mukunda Ray, MD, PhD and "Seasonal Patterns in Eosinophilic Esophagitis: An Analysis by Month of Diagnosis and Month of Birth" authored by Jennifer M. Hurrell, DO, Amnon Sonnenberg, MD, and Robert M. Genta, MD, FACG.
The first study found that young women with collagenous colitis are eight times more likely than the general population to have celiac disease. As a consequence of Dr. Bedeir's finding (in the largest series of young patients with collagenous colitis ever reported), it would seem appropriate to recommend that women age 40 or younger who have a diagnosis of collagenous colitis also undergo an EGD with duodenal biopsies to exclude concurrent celiac disease. The second study showed that, contrary to previous suggestions derived from smaller series, there was no evidence of monthly or seasonal variation even within known regions with diverse climates among our 10,000 patients with eosinophilic esophagitis.
"The establishment of the Caris Research Institute as a structure for promoting and carrying out research has again generated a strong presence at the annual ACG meeting in Washington, D.C.," Richard H. Lash, MD, Caris Diagnostics' Chief Medical Officer, commented. "We are committed to leveraging our tremendous database and academic talent to answer important questions in the field of gastroenterology and are honored to have the opportunity to present our findings at ACG 2011."
Full details on Caris Diagnostics' 13 remaining posters include:
About Caris Diagnostics
Caris Diagnostics, a leading provider of expert subspecialty pathology services, is focused on improving patient care through research and ongoing education of our faculty. The company's CarisPath™ expert GI pathology services provide academic caliber, consensus-based, clinically relevant diagnostic and prognostic information to clinicians. The company is headquartered in the Dallas metroplex and operates laboratories at the headquarters as well as in the Phoenix and Boston metro areas.
Media Inquiries: Holly Clark Caris Life Sciences 214-596-7060